Repligen | RGEN - Market Capitalization



Repligen reported $6.72B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Agilent USD 35.84B 3.23B Sep/2025
Align Technology USD 13.72B 2.09B Jun/2025
Bio Techne USD 8.07B 1.2B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Bruker USD 6.24B 89M Jun/2025
Charles River Laboratories USD 7.37B 25M Jun/2025
Danaher USD 142.28B 4.39B Jun/2025
Dentsply International USD 3.16B 188M Jun/2025
Exact Sciences USD 10.02B 1.86B Jun/2025
General Electric Aerospace USD 274.48B 61B Jun/2025
Henry Schein USD 9.16B 786M Jun/2025
Illumina USD 15.1B 2.54B Jun/2025
IQVIA Holdings USD 27.26B 3.82B Jun/2025
Mettler Toledo International USD 24.41B 201M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Repligen USD 6.99B 160M Jun/2025
Revvity USD 11.53B 1.18B Jun/2025
Standard Biotools USD 469M 35M Sep/2025
Thermo Fisher Scientific USD 154.12B 33.72B Jun/2025
Waters USD 20.97B 956M Jun/2025
West Pharmaceutical Services USD 15.72B 465M Jun/2025